
|Articles|November 15, 2003
AMO sharpens focus on innovative technology
Author(s)Mark L. Dlugoss
A sign of an excellent company is one that capitalizes on its strengths, minimizes its weaknesses, takes advantage of its opportunities, and recognizes its threats, according to James V. Mazzo, president and chief executive officer of Advanced Medical Optics (AMO).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
2
FDA accepts resubmitted ONS-5010 BLA from Outlook Therapeutics
3
When policy meets parenthood: Examining residency leave in ophthalmology
4
Five-year GALE study data announced
5



















































.png)


